Engineered imine reductases and methods for the reductive amination of ketone and amine compounds

US11060072B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11060072-B2
Application numberUS-201916525834-A
CountryUS
Kind codeB2
Filing dateJul 30, 2019
Priority dateNov 13, 2013
Publication dateJul 13, 2021
Grant dateJul 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for preparing an amine compound of formula (III), wherein R 1 and R 2 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl; and optionally R 1 and R 2 are linked to form a 3-membered to 10-membered ring; R 3 and R 4 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl, with the proviso that both R 3 and R 4 cannot be hydrogen; and optionally R 3 and R 4 are linked to form a 3-membered to 10-membered ring; and optionally, the carbon atom and/or the nitrogen indicated by * is chiral; the process comprising contacting a compound of formula (I), wherein R 1 , and R 2 are as defined above; and a compound of formula (II), wherein R 3 , and R 4 are as defined above; with an engineered polypeptide, wherein the engineered polypeptide has imine reductase activity in presence of a cofactor under suitable reaction conditions and wherein the engineered polypeptide comprises an amino acid sequence with at least 90 sequence identity to a reference sequence of SEQ ID NO:6 and a residue difference at position 82, as compared to SEQ ID NO:6. 2. The process of claim 1 , in which R 3 and R 4 are linked to form a 3-membered to 10-membered ring. 3. The process of claim 1 , in which the substrate compound of formula (II) is butylamine. 4. The process of claim 1 , in which at least one of R 1 and R 2 of the compound of formula (I) is linked to at least one of R 3 and R 4 of the amine compound of formula (II), whereby the process for preparing the amine compound of formula (III) comprises an intramolecular reaction. 5. The process of claim 1 , in which the suitable reaction conditions comprise: (a) substrate loading at about 10 g/L to 100 g/L; (b) about 0.1 g/L to about 50 g/L of the engineered polypeptide; (c) about 0.05 g/L (0.001 M) to about 2.5 g/L (0.050 M) of NAD(P)H; (d) a pH of about 6 to 10; (e) temperature of about 20° to 50° C.; and (f) reaction time of 2-120 hrs. 6. The process of claim 1 , in which the substrate compound of formula (I) is compound (1j): 7. The process of claim 1 , wherein the process comprises contacting butylamine and the substrate compound (1j): with an engineered polypeptide, wherein the engineered polypeptide has imine reductase activity in the presence of a cofactor under suitable reaction conditions and wherein the engineered polypeptide comprises an amino acid sequence with at least 90 sequence identity to a reference sequence of SEQ ID NO:6 and a residue difference at position 82, as compared to SEQ ID NO:6, to produce the product of compound (3o):

Assignees

Inventors

Classifications

  • C12N9/0028Primary

    with NAD or NADP as acceptor (1.5.1) · CPC title

  • Nitrogen as only ring hetero atom · CPC title

  • Opine dehydrogenase (1.5.1.28) · CPC title

  • Amines; Imines · CPC title

  • C07K14/305Primary

    from Micrococcaceae (F) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11060072B2 cover?
The present application provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.
Who is the assignee on this patent?
Codexis Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/0028. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).